Filter News
Area of Research
- (-) Fusion and Fission (1)
- (-) Nuclear Science and Technology (2)
- Biological Systems (1)
- Biology and Environment (16)
- Clean Energy (6)
- Computational Biology (2)
- Computational Engineering (1)
- Isotopes (5)
- Materials (7)
- Materials for Computing (2)
- National Security (2)
- Neutron Science (11)
- Supercomputing (17)
News Type
News Topics
- (-) Biomedical (3)
- 3-D Printing/Advanced Manufacturing (7)
- Advanced Reactors (17)
- Artificial Intelligence (1)
- Bioenergy (2)
- Biology (1)
- Buildings (1)
- Chemical Sciences (4)
- Composites (1)
- Computer Science (4)
- Coronavirus (1)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (3)
- Energy Storage (4)
- Environment (3)
- Exascale Computing (1)
- Fossil Energy (1)
- Frontier (1)
- Fusion (30)
- Grid (2)
- High-Performance Computing (2)
- Isotopes (6)
- ITER (6)
- Materials (1)
- Materials Science (7)
- Microscopy (1)
- Molten Salt (4)
- Nanotechnology (1)
- Net Zero (1)
- Neutron Science (6)
- Nuclear Energy (61)
- Partnerships (3)
- Physics (3)
- Security (2)
- Simulation (3)
- Space Exploration (6)
- Sustainable Energy (5)
- Transformational Challenge Reactor (3)
- Transportation (2)
Media Contacts
![Debjani Pal’s photo “Three-Dimensional Breast Cancer Spheroids” won the Director’s Choice Award in Oak Ridge National Laboratory’s Art of Science photo competition. It will be displayed at the American Museum of Science and Energy in Oak Ridge, Tenn. Credit: Debjani Pal/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2023-12/ArtofSci23_1700166411096.png?h=a06d9019&itok=lbq0KEuH)
“Three-Dimensional Breast Cancer Spheroids” submitted by radiotherapeutics researcher Debjani Pal is stunning. Brilliant blue dots pop from an electric sphere threaded with bright colors: greens, aqua, hot pink and red.
![Solid radium sulfate sits in the bottom of a flask during the recovery process. Credit: Oak Ridge National Laboratory, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-06/Ac227%202.jpg?h=479d286c&itok=AiNceGva)
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.